The Evolving Rationale for Early Enteral Nutrition Based on Paradigms of Multiple Organ Failure: A Personal Journey

Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am.1995 ;75:257 -277.

Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma—a prospective, randomized study. J Trauma. 1986;26:874 -881.

Borlase BC, Moore EE, Moore FA. The abdominal trauma index—a critical reassessment and validation. J Trauma.1990 ;30:1340 -1344.

Jones TN, Moore FA, Moore EE, McCroskey BL. Gastrointestinal symptoms attributed to jejunostomy feeding after major abdominal trauma: a critical analysis. Crit Care Med.1989 ;17:1146 -1150.

Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma. 1989;29:916 -923.

Moore FA, Moore EE, Kudsk KA, et al. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma. 1994;37:607 -615.

Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg.1992 ;216:172 -183.

Kudsk KA, Croce MA, Fabian TC, et al. Enteral versus parenteral feeding. Ann Surg.1992 ;215:503 -513.

Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. Ann Surg. 1996;224:531 -543.

Border JR, Hassett J, LaDuca J, et al. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg. 1987;206:427 -448.

Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the “undrained abscess” of multiple organ failure. Ann Surg. 1993;218:111 -119.

Deitch EA, Winterton J, Li MA, Berg R. The gut as a portal of entry for bacteremia. Ann Surg.1987 ;205:681 -692.

Peterson VM, Moore EE, Jones TN, et al. Total enteral nutrition versus total parenteral nutrition after major torso injury: attenuation of hepatic protein reprioritization. Surgery.1988 ;104:199 -207.

Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991;31:629 -636.

Moore EE, Moore FA, Franciose RJ, Kim FJ, Biffl WL, Banerjee A. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma.1994 ;37:881 -877.

Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma. 1996;40:501 -510.

Moore FA, Peterson VM, Moore EE, Rundus C, Poggetti R. Inadequate granulopoiesis after major torso trauma: a hematopoietic regulatory paradox. Surgery. 1990;108:667 -674.

Botha AJ, Moore FA, Moore EE, Fontes B, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation states: therapeutic challenges. Shock. 1995;3:157 -166.

Faist E, Mewes A, Baker CC, et al. Prostaglandin E2 (PGE2) dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma.1987 ;27:837 -848.

Miller-Graziano CL, Szabo G, Griffey K, Mehta B, Kodys K, Catalano D. Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression. J Clin Immunol. 1991;11:95 -102.

Ayala A, Lehman DL, Herdon CD, Chaudry IH. Mechanism of enhanced susceptibility to sepsis following hemorrhage: interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch Surg.1994 ;129:1172 -1178.

Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC Jr. Lymphocyte subset responses to trauma and sepsis. J Trauma. 1993;35:844 -849.

Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg.2001 ;193:237 -244.

Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996;125:680 -687.

Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001;16:83 -96.

Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med.2003 ;348:138 -150.

Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med.2007 ;35:2408 -2416.

Jordan JR, Moore EE, Sarin EL, et al. Arachidonic acid in post-shock mesenteric lymph induces pulmonary synthesis of leukotriene B4. J Appl Physiol.2008 ;104:1161 -1166.

Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg.1999 ;178:449 -453.

Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15:1 -10.

Moore FA, Weisbrodt NW. Gut dysfunction and intolerance to enteral nutrition in critically ill patients. Nestle Nutr Workshop Ser Clin Perform Programme. 2003;8:149 -165.

Kozar RA, Weisbrodt NW, Moore FA. Gastrointestinal failure. In: Feliciano DV, Mattox KL, Moore EE, eds. Trauma. 6th ed. New York, NY: McGraw-Hill; 2008;:1281 -1290.

Kazamias P, Kotzampassi K, Koufogiannis D, Eleftheriadis E. Influence of enteral nutrition-induced splanchnic hyperemia on the septic origin of splanchnic ischemia. World J Surg.1998 ;22:6 -11.

Flynn WJ Jr, Gosche JR, Garrison RN. Intestinal blood flow is restored with glutamine or glucose suffusion after hemorrhage. J Surg Res. 1992;52:499 -504.

Grossie VB Jr, Weisbrodt NW, Moore FA, Moody F. Ischemia/reperfusion-induced disruption of rat small intestine transit is reversed by total enteral nutrition. Nutrition.2001 ;17:939 -943.

Nieuwenhuijs VB, Verheem A, van Duijvenbode-Beumer H, et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg.1998 ;228:188 -193.

De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005;33:1125 -1135.

Kang W, Kudsk KA. Is there evidence that the gut contributes to mucosal immunity in humans? JPEN J Parenter Enteral Nutr. 2007;31:246 -258.

Kang W, Gomez FE, Lan J, Sano Y, Ueno C, Kudsk KA. Parenteral nutrition impairs gut-associated lymphoid tissue and mucosal immunity by reducing lymphotoxin Beta receptor expression. Ann Surg. 2006;244:392 -399.

Cerra FB, Lehmann S, Konstantinides N, et al. Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition. 1991;7:193 -199.

Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg.1988 ;208:512 -523.

Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr.1990 ;14:225 -236.

Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992;112:56 -67.

McClave SA, Demeo MT, Delegge MH, et al. North American Summit on Aspiration in the critically ill patient: consensus statement. JPEN J Parenter Enteral Nutr.2002 ;26(6 suppl):S80 -S85.

Bertolini G, Lapichino G, Radrizzani D, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med. 2003;29:834 -840.

Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA.2001 ;286:944 -953.

Suchner U, Heyland DK, Peter K. Immune-modulatory actions of arginine in the critically ill. Br J Nutr.2002 ;87(suppl 1):S1212 -S132.

Ochoa JB, Makarenkova V, Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplementation? Nutr Clin Pract.2004 ;19:216 -225.

Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg.2005 ;140:432 -438.

Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med.2007 ;35:1244 -1250.

Suliburk J, Helmer K, Moore FA, Mercer D. The gut in systemic inflammatory response syndrome and sepsis: enzyme systems fighting multiple organ failure. Eur Surg Res.2008 ;40:184 -189.

Mannick JA. 15th Annual Semmelweis Lecture Surgical Infection Society-Europe. Injury-induced immune dysfunction: is the lymphocyte irrelevant? Surg Infect.2002 ;3:297 -302.

Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol.2006 ;177:1967 -1974.

Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG. Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol.2007 ;179:623 -630.

Maier B, Lefering R, Lehnert M, et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock. 2007;28:668 -674.

Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infect Immun.2006 ;74:5227 -5235.

Van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet.1998 ;351:950 -953.

Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176 -180.

Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med.2007 ;35:2016 -2024.

Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167:1655 -1663.

McClave SA, Chang WK. Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel? Nutr Clin Pract. 2003;18:279 -284.

Kozar RA, Verner-Cole E, Schultz SG, et al. The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J Trauma. 2004;57:1150 -1156.

Sato N, Moore FA, Smith MA, et al. Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma.2005 ;58:455 -461.

Sato N, Moore FA, Kone BC, et al. Differential induction of PPAR-γ by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol. 2006;290:G616 -G623.

Reeds PJ, Burrin DG. Glutamine and the bowel. J Nutr. 2001;131 (9 suppl): 2505S-2508S.

Thomas S, Prabhu R, Balasubramanian KA. Surgical manipulation of the intestine and distant organ damage-protection by oral glutamine supplementation. Surgery.2005 ;137:48 -55.

Blikslager AT, Rhoads JM, Bristol DG, Roberts MC, Argenzio RA. Glutamine and transforming growth factor-alpha stimulate extracellular regulated kinases and enhance recovery of villous surface area in porcine ischemic-injured intestine. Surgery.1999 ;125:186 -194.

McQuiggan M, Kozar R, Sailors RM, Ahn C, McKinley B, Moore F. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr. 2008;32:28 -35.

Kozar RA, McQuiggan MM, Moore EE, Kudsk KA, Jurkovich GJ, Moore FA. Postinjury enteral tolerance is reliably achieved by a standardized protocol. J Surg Res.2002 ;104:70 -75.